Related Experiment Video
Updated: Apr 18, 2026

Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis
Published on: May 8, 2021
Urine proteomic profiling at admission reveals complement biomarkers linked to alcohol-associated liver disease
Insights
Urinary complement proteins may serve as biomarkers for alcohol-associated liver disease (ALD) and alcohol-associated hepatitis (AH), offering insights into liver-kidney crosstalk. These findings could aid in distinguishing AH from alcohol cirrhosis (AC).
Area of Science:
- Immunology
- Nephrology
- Hepatology
Background:
- Circulating complement is linked to alcohol-associated hepatitis (AH) and can differentiate it from alcohol cirrhosis (AC).
- Complement activation contributes to kidney injury in alcohol-associated liver disease (ALD), but liver-kidney crosstalk mechanisms remain unclear.
- This study investigates urinary complement as potential biomarkers for ALD and liver-kidney crosstalk.
Purpose of the Study:
- To test the hypothesis that urinary complement proteins can serve as biomarkers for ALD.
- To gain insights into the mechanisms of liver-kidney crosstalk in ALD pathogenesis.
- To evaluate the potential of urinary complement to distinguish between severe AH (sAH) and AC.
Main Methods:
- Collected plasma and urine samples from patients with sAH, healthy controls (HC), heavy drinkers (HD), and patients with AC.
- Performed unbiased proteomics analysis on urine samples.
- Assessed plasma complement using multiplex/ELISA assays and tracked 30- and 90-day mortality in sAH patients.
Main Results:
- All three complement pathways were altered in plasma and urine of sAH and AC patients compared to HC and HD.
- Urinary complement components correlated with mortality in sAH patients.
- A panel of four urinary complement proteins distinguished sAH from AC with an AUC of 0.78, comparable to MELD (AUC 0.65).
- No correlation was found between plasma and urinary complement levels.
Conclusions:
- Urinary proteomic analysis identified complement protein signatures associated with sAH and AC.
- Urinary complement shows potential as biomarkers for ALD.
- Findings provide insights into liver-kidney crosstalk mechanisms in ALD pathogenesis.
Background And Aims:
Circulating complement is associated with occurrence of alcohol-associated hepatitis (AH) and is a potential biomarker to distinguish AH from alcohol cirrhosis (AC). Complement contributes to kidney injury, a condition often occurring in patients with alcohol-associated liver disease (ALD). However, little is known regarding complement in cross talk between liver and kidney in ALD. Here we tested the hypothesis that urinary complement would provide potential biomarkers for ALD and insights into mechanisms of liver-kidney crosstalk in the pathogenesis of ALD.
Methods:
Plasma and urine were collected at admission from patients with sAH, healthy controls (HC), and heavy drinkers without liver disease (HD) (from the multicenter Alcohol Hepatitis Network) and with AC (from the Northern Ohio Alcohol Center). Urine was subjected to unbiased proteomics analysis and plasma complement assessed by multiplex/ELISA assays. 30- and 90-day mortality was tracked in patients with sAH.
Results:
All three complement activation pathways were perturbed in plasma and urine of patients with sAH and AC compared to HC and HD. Components of the lectin and classical pathways in urine were associated with 30- and 90-day mortality in patients with sAH. When 4 complement proteins were combined, they distinguished sAH from AC (AUC 0.78), equivalent to that of MELD (AUC 0.65). There was no correlation between complement in plasma and urine, suggesting an independent impact of sAH on complement in kidney and liver.
Conclusion:
The urinary proteome revealed complement protein signatures associated with sAH and AC, providing valuable insights into the potential for complement biomarkers and the mechanisms of liver-kidney crosstalk in ALD.
Related Concept Videos
Urine Studies I: Urinalysis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
